Impact of Anti-Inflammatory Drugs on Pyogenic Vertebral Osteomyelitis: A Prospective Cohort Study
Author(s) -
Aurélien Dinh,
Maxime Jean,
Frédérique Bouchand,
Benjamin Davido,
Alexis Descatha,
Clara Duran,
Guillaume Gras,
Christian Perronne,
Denis Mulleman,
Jérôme Salomon,
Louis Bernard
Publication year - 2016
Publication title -
international journal of rheumatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.8
H-Index - 33
eISSN - 1687-9279
pISSN - 1687-9260
DOI - 10.1155/2016/9345467
Subject(s) - medicine , vertebral osteomyelitis , osteomyelitis , prospective cohort study , cohort , cohort study , intensive care medicine , surgery
Objective . Pyogenic vertebral osteomyelitis (PVO) are frequently misdiagnosed and patients often receive anti-inflammatory drugs for their back pain. We studied the impact of these medications. Methods . We performed a prospective study enrolling patients with PVO and categorized them depending on their drugs intake. Then, we compared diagnosis delay, clinical presentation at hospitalization, incidence of complications, and cure rate. Results . In total, 79 patients were included. Multivariate analysis found no correlation between anti-inflammatory drug intake and diagnosis delay, clinical presentation, complications, or outcome. Conclusion . Anti-inflammatory drugs intake does not affect diagnostic delay, severity at diagnosis, or complications of PVO.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom